Pfizer Ltd. — Interim / Quarterly Report 2024

Oct 28, 2023

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

October 28, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Statement of Related Party Transactions for the half year ended September 30, 2023.

Ref.: Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’).

Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2023.

The said disclosure is also available on the website of the Company i.e., www.pfizerltd.co.in

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

PRAJEET NAIR

Digitally signed by PRAJEET NAIR Date: 2023.10.28 16:32:26 +05'30'

Prajeet Nair Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in

Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015

												Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.	Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr. no	Details of the party listed entity entering into the transaction		Details of the counter party			Type of related party transaction	Value of the related party transaction as approved by the audit committee	Remarks on approval by Audit Committee	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction		In case any financial indebtedness is incurred to make or give loans, inter- corporate deposits, advances or investments			Details of the loans, inter-corporate deposits, advances or investments
	Name	PAN	Name	PAN	Relationship of the counterparty with the listed entity or its subsidiary					Opening balance	Closing balance	Nature of indebtedness (loan/ issuance of debt/ any other etc.)	**Cost **	**Tenure **	Nature (loan/ advance/ inter- corporate deposit/ investment	Interest Rate (%)	**Tenure **	Secured/ unsecured	Purpose for which the funds will be utilised by the ultimate recipient of funds (end- usage)
1	Pfizer Limited	AAACP3334M	Pfizer Service Company BVBA, Belgium	ZZZZZ9999Z	Fellow subsidiary	Purchase of Goods & Services	220.68	On arm's length basis and in Ordinary course of business	220.68	83.56	54.99	Not Applicable
2	Pfizer Limited	AAACP3334M	Pfizer Healthcare India Private Limited	AABCO2190F	Fellow subsidiary	Service Income	1.96	On arm's length basis and in Ordinary course of business	1.96	-4.05	-2.48	Not Applicable
3	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	AADCP8985B	Fellow subsidiary	Service Income	14.12	On arm's length basis and in Ordinary course of business	14.12	-9.58	-14.31	Not Applicable
4	Pfizer Limited	AAACP3334M	Pfizer Export B.V.	ZZZZZ9999Z	Fellow subsidiary	Service Income	0.16	On arm's length basis and in Ordinary course of business	0.16	0	-0.15	Not Applicable
5	Pfizer Limited	AAACP3334M	Pfizer Worldwide Services Company	ZZZZZ9999Z	Fellow subsidiary	Service Income	35.65	On arm's length basis and in Ordinary course of business	35.65	-20.19	-26.41	Not Applicable
6	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	AADCP8985B	Fellow subsidiary	Recovery of expense	0.19	On arm's length basis and in Ordinary course of business	0.19	0	0	Not Applicable
7	Pfizer Limited	AAACP3334M	Pfizer Healthcare India Private Limited	AABCO2190F	Fellow subsidiary	Recovery of expense	0.45	On arm's length basis and in Ordinary course of business	0.45	0	0	Not Applicable
8	Pfizer Limited	AAACP3334M	Pfizer East India B. V	AAGCP7832A	Companies holding significant influence	Payment of Dividend	72.75	On arm's length basis and in Ordinary course of business	72.75	0	0	Not Applicable
9	Pfizer Limited	AAACP3334M	Wyeth LLC	AADCA9739J	Companies holding significant influence	Payment of Dividend	22.47	On arm's length basis and in Ordinary course of business	22.47	0	0	Not Applicable
10	Pfizer Limited	AAACP3334M	Wyeth Holdings LLC	AAACA5142N	Companies holding significant influence	Payment of Dividend	6.52	On arm's length basis and in Ordinary course of business	6.52	0	0	Not Applicable
11	Pfizer Limited	AAACP3334M	Warner Lambert Company LLC	AAACW4997K	Companies holding significant influence	Payment of Dividend	4.75	On arm's length basis and in Ordinary course of business	4.75	0	0	Not Applicable
12	Pfizer Limited	AAACP3334M	Parke,Davis & Company LLC	AADCP1134C	Companies holding significant influence	Payment of Dividend	3.82	On arm's length basis and in Ordinary course of business	3.82	0	0	Not Applicable
13	Pfizer Limited	AAACP3334M	John Wyeth & Brother Limited	AAACJ1732F	Companies holding significant influence	Payment of Dividend	3.53	On arm's length basis and in Ordinary course of business	3.53	0	0	Not Applicable
14	Pfizer Limited	AAACP3334M	Pharmacia LLC	AAECP7868A	Companies holding significant influence	Payment of Dividend	3.14	On arm's length basis and in Ordinary course of business	3.14	0	0	Not Applicable
15	Pfizer Limited	AAACP3334M	Ms. Meenakshi Nevatia	ABSPN7808E	Key Managerial Personnel	Remuneration	3.86	On arm's length basis and in Ordinary course of business	3.86	0	0	Not Applicable
16	Pfizer Limited	AAACP3334M	Mr. Milind Patil	AAEPP3949B	Key Managerial Personnel	Remuneration	1.92	On arm's length basis and in Ordinary course of business	1.92	0	0	Not Applicable

17	Pfizer Limited	AAACP3334M	Mr. Samir Kazi*	AJSPK0243Q	Key Managerial Personnel	Remuneration	1.39	On arm's length basis and in Ordinary course of business	1.39	0	0	Not Applicable
18	Pfizer Limited	AAACP3334M	Mr. Prajeet Nair	AADPN9155G	Key Managerial Personnel	Remuneration	0.52	On arm's length basis and in Ordinary course of business	0.52	0	0	Not Applicable
19	Pfizer Limited	AAACP3334M	Mr. Pradip Shah	AAEPS0592F	Independent Director	Sitting Fees	0.04	On arm's length basis and in Ordinary course of business	0.04	0	0	Not Applicable
20	Pfizer Limited	AAACP3334M	Mr. Uday Khanna	AFEPK7061E	Independent Director	Sitting Fees	0.03	On arm's length basis and in Ordinary course of business	0.03	0	0	Not Applicable
21	Pfizer Limited	AAACP3334M	Mr. Sunil Lalbhai	AAFPL0691R	Independent Director	Sitting Fees	0.03	On arm's length basis and in Ordinary course of business	0.03	0	0	Not Applicable
22	Pfizer Limited	AAACP3334M	Ms. Meena Ganesh	ABPPG1456L	Independent Director	Sitting Fees	0.02	On arm's length basis and in Ordinary course of business	0.02	0	0	Not Applicable

• Mr. Samir Kazi ceased to be the Executive Director - Legal of the Company effective September 12, 2023 close of business